We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

48 hedge funds and large institutions have $13.9M invested in Perspective Therapeutics in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.08% less ownership

Funds ownership: 1.31% → 1.23% (-0.08%)

16% less funds holding

Funds holding: 57 → 48 (-9)

18% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 11

31% less capital invested

Capital invested by funds: $20.2M → $13.9M (-$6.32M)

53% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 17

Holders
48
Holders Change
-9
Holders Change %
-15.79%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
9
Reduced
11
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$445K
2
PCM
Perkins Capital Management
Minnesota
+$223K
3
BA
Bard Associates
Illinois
+$135K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$118K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$65.2K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$595K
2
BlackRock
BlackRock
New York
-$506K
3
BCM
Bridgeway Capital Management
Texas
-$228K
4
MS
Maven Securities
Jersey
-$167K
5
VF
Virtu Financial
New York
-$128K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$4.88M -$77K -8,787 -1%
Renaissance Technologies
2
Renaissance Technologies
New York
$2.06M -$595K -67,993 -21%
BlackRock
3
BlackRock
New York
$1.97M -$506K -57,748 -19%
PCM
4
Perkins Capital Management
Minnesota
$1.32M +$223K +25,500 +18%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$892K +$118K +13,484 +14%
HPWM
6
Highland Private Wealth Management
Washington
$676K – – –
BA
7
Bard Associates
Illinois
$429K +$135K +15,440 +40%
State Street
8
State Street
Massachusetts
$414K +$445K +50,846 +4,806%
BCM
9
Bridgeway Capital Management
Texas
$219K -$228K -26,000 -49%
Northern Trust
10
Northern Trust
Illinois
$215K -$11.8K -1,348 -5%
Creative Planning
11
Creative Planning
Kansas
$91K -$88 -10 -0.1%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$80K +$65.2K +7,443 +300%
Morgan Stanley
13
Morgan Stanley
New York
$61K +$64.8K +7,402 +3,365%
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$49K – – –
Charles Schwab
15
Charles Schwab
California
$45K – – –
CAG
16
Crestwood Advisors Group
Massachusetts
$44K – – –
Citadel Advisors
17
Citadel Advisors
Florida
$41K -$62.2K -7,098 -58%
MIAN
18
Mariner Independent Advisor Network
Kansas
$38K +$41.8K +4,778 New
AF
19
Advisornet Financial
Minnesota
$34K +$10.4K +1,182 +38%
Cerity Partners
20
Cerity Partners
New York
$32K – – –
Commonwealth Equity Services
21
Commonwealth Equity Services
Massachusetts
$31K – – –
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$28K +$18.4K +2,100 +150%
CS
23
Candriam SCA
Luxembourg
$28K +$30.5K +3,488 New
VF
24
Virtu Financial
New York
$25K -$128K -14,619 -82%
CPIG
25
Chicago Partners Investment Group
Illinois
$24K – – –
1
2 3

CATX Hedge Fund Activity: Q2 2021 in Review

48 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q2 2021, worth a combined $13.9M — down 31% from $20.2M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CATX and 8 opened new positions — a net loss of 9 holders — while 11 trimmed existing stakes and 9 added.

The largest buyer was State Street, adding an estimated $445K. The largest seller was Renaissance Technologies, cutting an estimated $595K.

  • 48 institutional investors held Perspective Therapeutics (CATX) as of Q2 2021, down from 57 in Q1 2021.
  • Funds reported $13.9M of Perspective Therapeutics stock for Q2 2021, down 31% quarter-over-quarter.
  • 8 funds opened new Perspective Therapeutics positions in Q2 2021 and 17 closed out, a net change of -9 holders.
  • The largest Perspective Therapeutics buyer in Q2 2021 was State Street, an estimated $445K added.
  • The largest Perspective Therapeutics seller in Q2 2021 was Renaissance Technologies, an estimated $595K sold.

Based on aggregated 13F filings for Q2 2021.